InvestorsHub Logo
Followers 47
Posts 2077
Boards Moderated 0
Alias Born 10/30/2016

Re: Kicking Wing post# 74570

Thursday, 03/23/2017 9:28:23 AM

Thursday, March 23, 2017 9:28:23 AM

Post# of 203913
DEA Schedules Insys Therapeutics’ Syndros (dronabinol oral solution) as Schedule II Drug

Positive news for MMJ generally that the DEA has finally made a decision that this cannabinoid-based medicine can be moved from Schedule 1.


http://finance.yahoo.com/news/dea-schedules-i...25023.html OUR BUDDY TRIPLE 9 POSTED THIS ELSEWHERE!! :)